Clinical Trials Directory

Trials / Completed

CompletedNCT03402594

High Flow Oxygen Therapy and Acute Ischemic Stroke

Effects of High Flow Oxygen Therapy on Oxygen Desaturation Index in Patients With Acute Ischemic Stroke

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypoxemia is common in acute ischemic stroke and associated with neurological deterioration and mortality. However, the benefit of oxygen therapy is controversial. Severity of stroke may affect the benefit of oxygen supplementation. Abnormal breathing patterns are commonly found among stroke patients and may increase the risk of hypoxemia. High flow nasal cannula (HFNC) has several advantages from controllable fraction of inspired oxygen (FiO2), reduction of nasopharyngeal resistance and positive end expiratory pressure effect. In this study, we aimed to assess the therapeutic effect of HFNC on oxygen desaturation index (ODI) and neurological outcomes in stroke patients with moderate and severe severities, compared with no and low flow oxygen supplementation.

Conditions

Interventions

TypeNameDescription
DEVICEHigh flow oxygenHeated humidified high flow oxygen cannula (Optiflow; temperature of 34°C and fractional inspired oxygen of 0.24) with a flow rate of 20 liter/minute
DEVICELow flow oxygenOxygen cannula with a flow rate of 2 liter/minute

Timeline

Start date
2016-07-01
Primary completion
2017-03-31
Completion
2017-06-30
First posted
2018-01-18
Last updated
2018-01-18

Source: ClinicalTrials.gov record NCT03402594. Inclusion in this directory is not an endorsement.